RANEXA 500 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

RANOLAZINE 500 MG

Mevcut itibaren:

NEOPHARM LTD

ATC kodu:

C01EB18

Farmasötik formu:

TABLETS EXTENDED RELEASE

Uygulama yolu:

PER OS

Tarafından üretildi:

CV THERAPEUTICS INC, USA

Terapötik grubu:

RANOLAZINE

Terapötik endikasyonlar:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Yetkilendirme tarihi:

2010-10-01